Haleon, the maker of Robitussin, has issued a voluntary recall of eight lots of three varieties of its cough medicines due to microbial contamination. 

A regional poison control center suspects three cases of hypoglycemia in 2023 were linked to counterfeit versions of Ozempic, according to a Jan. 24 Reuters exclusive report.

A federal appeals court in New York has upheld an order that bars "pharma bro" Martin Shkreli from working in the pharmaceutical industry, according to court documents.

CVS Caremark will no longer handle pharmacy costs for Tyson Foods' 140,000 employees after the company cut its contract, CNBC reported Jan. 24. A few months ago, Blue Shield California curbed its yearslong partnership with the pharmacy benefit manager.

After discontinuing the use of semaglutide and liraglutide weight-loss medications, a majority of patients were able to maintain the same weight they were at when halting the use — or even continued to lose additional weight after one year, a…

The viral popularity of Ozempic, Wegovy, and other diabetes and weight loss drugs is affecting hospital operations in a roundabout way. 

The FDA is now calling for warning labels on all commercial CAR-T therapy products amid its investigation into 22 reports about a possible being linked to lymphoma. 

The FDA has published corrections and additions to a company's voluntary recall of eye drops after a wave of several others throughout 2023. 

A handful of pharmacists in Washington state are training to prescribe the abortion medication mifepristone, NPR reported Jan. 22. 

Over the last five years, Hagerstown, Md.-based Meritus Health cut the number of opiates prescribed by more than 55% in its effort to quell the national opioid epidemic.